Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
Purification and Characterization of Mouse Hematopoietic Stem Cells
1988 • 2,856 citations
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
1990 • 1,544 citations
Isolation of a candidate human hematopoietic stem-cell population.
1992 • 1,098 citations
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
1985 • 517 citations
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
1993 • 356 citations
Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease
1999 • 312 citations
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
1998 • 305 citations
Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
1994 • 298 citations
Treatment of Donor Bone Marrow with Monoclonal Anti-T-Cell Antibody and Complement for the Prevention of Graft-Versus-Host Disease
1986 • 275 citations
Spontaneous murine B-cell leukaemia
1978 • 264 citations
Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
1993 • 195 citations
Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
1987 • 170 citations
Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
1991 • 154 citations
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia
1990 • 150 citations
Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
1996 • 137 citations
Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
1996 • 124 citations
The Tumor Dormant State
1981 • 123 citations
Interleukin-12 Preserves the Graft-Versus-Leukemia Effect of Allogeneic CD8 T Cells While Inhibiting CD4-Dependent Graft-Versus-Host Disease in Mice
1997 • 110 citations
Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection.
1994 • 106 citations
BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor
1979 • 95 citations
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments]
1994 • 93 citations
Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia
1990 • 89 citations
Graft vs. Host Disease
2004 • 75 citations
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
1990 • 71 citations
Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
1992 • 67 citations
Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
1979 • 64 citations
Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.
1986 • 64 citations
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
1985 • 58 citations
Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice
1997 • 56 citations
In vitro and in vivo analysis of bone marrow-derived CD3+, CD4−, CD8−, NK1.1+ cell lines
1990 • 55 citations
Donor Lymphocyte Infusion for the Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
1998 • 50 citations
Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
1983 • 49 citations
Murine B Cell Leukemia (BCL1): Organ Distribution and Kinetics of Growth as Determined by Fluorescence Analysis with an Anti-Idiotypic Antibody
1979 • 43 citations
The Pathology and Homing of a Transplantable Murine B Cell Leukemia (BCL1)
1979 • 37 citations
11 Donor leukocyte infusions
1997 • 24 citations
THE EFFECT OF HUMAN IL-2-ACTIVATED NATURAL KILLER AND T CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA IN SCID MICE BEARING HUMAN LEUKEMIC CELLS
1995 • 23 citations
Evidence for a possible role of Asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia.
1995 • 22 citations